INFINITY-EXT
Showing 1 - 25 of 126
Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)
Enrolling by invitation
- Diabetic Macular Edema
- Diabetic Retinopathy
- ADVM-022
-
Beverly Hills, California
- +6 more
Nov 4, 2022
INFINITY™ With ADAPTIS™ Technology Study
Recruiting
- Arthritis, Rheumatoid
- INFINITY™ with ADAPTIS™ Technology Total Ankle System
-
Gilbert, Arizona
- +11 more
Jan 3, 2023
Pantothenate Kinase-Associated Neurodegeneration Trial (Deferiprone)
No longer available
- Pantothenate Kinase-Associated Neurodegeneration
- (no location specified)
Nov 9, 2022
Coronary Artery Disease, Ischemic Heart Disease Trial in Sweden (DynamX Bioadaptor, Resolute Onyx)
Recruiting
- Coronary Artery Disease
- Ischemic Heart Disease
- DynamX Bioadaptor
- Resolute Onyx
-
Eskilstuna, Sweden
- +18 more
Jul 18, 2022
Adalimumab Trial in Cypress, South Miami, Salt Lake City (ABP 501-HCF, ABP 501-LCF)
Completed
- Adalimumab
- ABP 501-HCF
- ABP 501-LCF
-
Cypress, California
- +2 more
Jun 9, 2023
Growth Hormone Deficiency (GHD) Trial in Worldwide (MOD-4023)
Active, not recruiting
- Growth Hormone Deficiency (GHD)
-
Jacksonville, Florida
- +12 more
Apr 18, 2022
UK Infinity, Post-Market Clinical Follow-up Study
Active, not recruiting
- Arthritis, Rheumatoid
-
Torquay, Devon, United Kingdom
- +11 more
Feb 7, 2022
INFINITY™Total Ankle Replacement Follow-up
Active, not recruiting
- Arthritis, Rheumatoid
-
Rancho Mirage, California
- +8 more
Jan 5, 2022
Parkinson Disease Trial in Worldwide (Omnidirectional stimulation, Directional stimulation)
Completed
- Parkinson Disease
- Omnidirectional stimulation
- Directional stimulation
-
Sacramento, California
- +48 more
Jun 28, 2022
Gastric Cancer, Microsatellite Instability Trial in Milan (Durvalumab, Tremelimumab)
Recruiting
- Gastric Cancer
- Microsatellite Instability
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori di Milano
Aug 3, 2022
End-Stage Renal Disease, End-Stage Kidney Disease, Kidney Failure, Chronic Trial in Edgewater, Tampa (MK-2060, Placebo)
Recruiting
- End-Stage Renal Disease
- +2 more
- MK-2060
- Placebo
-
Edgewater, Florida
- +1 more
Jan 30, 2023
Deep Brain Stimulation for Parkinson's Disease (FoRMA-DBS)
Withdrawn
- Parkinson Disease
- (no location specified)
Jul 11, 2022
Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]
Enrolling by invitation
- Wet Age-related Macular Degeneration
- Neovascular Age-related Macular Degeneration
- ADVM-022
-
Bakersfield, California
- +8 more
Dec 23, 2021
Diabetic Macular Edema, Diabetic Retinopathy Trial in Puerto Rico, United States (6E11 vg/eye of ADVM-022, 2E11 vg/eye of
Active, not recruiting
- Diabetic Macular Edema
- Diabetic Retinopathy
- 6E11 vg/eye of ADVM-022
- +2 more
-
Phoenix, Arizona
- +13 more
Jan 10, 2022
Breast Cancer, Renal Cell Carcinoma Trial in United States (IPI-549 (eganelisib), Atezolizumab, nab-paclitaxel)
Active, not recruiting
- Breast Cancer
- Renal Cell Carcinoma
- IPI-549 (eganelisib)
- +3 more
-
Chandler, Arizona
- +23 more
Apr 1, 2022
PAD - Peripheral Arterial Disease, Vascular Diseases, Wounds Trial (PIUR tUS Imaging System)
Not yet recruiting
- PAD - Peripheral Arterial Disease
- +2 more
- PIUR tUS Imaging System
- (no location specified)
Sep 27, 2022
Biliary Stricture, Jaundice, Obstructive Trial in Charenton-le-Pont (Biliary brushing with the RX Cytology brush, Boston
Completed
- Biliary Stricture
- Jaundice, Obstructive
- Biliary brushing with the RX Cytology brush, Boston Scientific
- Biliary brushing with the Infinity® brush, US Endoscopy
-
Charenton-le-Pont, FranceClinique Paris Bercy
Jun 17, 2022